PRIMARY BILIARY CIRRHOSIS
Clinical trials for PRIMARY BILIARY CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CIRRHOSIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare liver disease: drug shows promise in reducing damage and symptoms
Disease control OngoingThis study tests a new drug called elafibranor in people with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. Participants either did not get enough help from or could not take the standard medicine. The goal is to see if elafi…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for PBC patients: Long-Term safety trial of seladelpar underway
Disease control OngoingThis study is testing the long-term safety of a drug called seladelpar in people with primary biliary cholangitis (PBC), a chronic liver disease. About 340 adults who have taken seladelpar before will receive either 5 mg or 10 mg daily for several years. Researchers will monitor …
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC